Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 2008, 58: 71-96. 10.3322/CA.2007.0010.
Article
PubMed
Google Scholar
Jemal A, Center MM, Ward E, Thun MJ: Cancer occurrence. Methods Mol Biol. 2009, 471: 3-29. 10.1007/978-1-59745-416-2_1.
Article
PubMed
Google Scholar
Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 2005, 55: 74-108. 10.3322/canjclin.55.2.74.
Article
PubMed
Google Scholar
Dobrossy L: Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev. 2005, 24: 9-17. 10.1007/s10555-005-5044-4.
Article
PubMed
Google Scholar
Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, et al: Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004, 350: 1937-1944. 10.1056/NEJMoa032646.
Article
PubMed
Google Scholar
Woolgar JA, Rogers SN, Lowe D, Brown JS, Vaughan ED: Cervical lymph node metastasis in oral cancer: the importance of even microscopic extracapsular spread. Oral Oncol. 2003, 39: 130-137. 10.1016/S1368-8375(02)00030-1.
Article
CAS
PubMed
Google Scholar
Myers JN, Greenberg JS, Mo V, Roberts D: Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer. 2001, 92: 3030-3036. 10.1002/1097-0142(20011215)92:12<3030::AID-CNCR10148>3.0.CO;2-P.
Article
CAS
PubMed
Google Scholar
Hocking AM, Shinomura T, McQuillan DJ: Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 1998, 17: 1-19. 10.1016/S0945-053X(98)90121-4.
Article
CAS
PubMed
Google Scholar
Iozzo RV: The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem. 1999, 274: 18843-18846. 10.1074/jbc.274.27.18843.
Article
CAS
PubMed
Google Scholar
Kobe B, Kajava AV: The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol. 2001, 11: 725-732. 10.1016/S0959-440X(01)00266-4.
Article
CAS
PubMed
Google Scholar
Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I: Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem. 1999, 274: 4489-4492. 10.1074/jbc.274.8.4489.
Article
CAS
PubMed
Google Scholar
Santra M, Reed CC, Iozzo RV: Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope. J Biol Chem. 2002, 277: 35671-35681. 10.1074/jbc.M205317200.
Article
CAS
PubMed
Google Scholar
Iozzo RV: Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem. 1998, 67: 609-652. 10.1146/annurev.biochem.67.1.609.
Article
CAS
PubMed
Google Scholar
Zhu JX, Goldoni S, Bix G, Owens RT, McQuillan DJ, Reed CC, Iozzo RV: Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis. J Biol Chem. 2005, 280: 32468-32479. 10.1074/jbc.M503833200.
Article
CAS
PubMed
Google Scholar
Seidler DG, Goldoni S, Agnew C, Cardi C, Thakur ML, Owens RT, McQuillan DJ, Iozzo RV: Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation. J Biol Chem. 2006, 281: 26408-26418. 10.1074/jbc.M602853200.
Article
CAS
PubMed
Google Scholar
Iozzo RV, Cohen I: Altered proteoglycan gene expression and the tumor stroma. Experientia. 1993, 49: 447-455. 10.1007/BF01923588.
Article
CAS
PubMed
Google Scholar
McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA, You M: Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res. 2002, 8: 1127-1138.
CAS
PubMed
Google Scholar
Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, et al: Genetic analysis of early- versus late-stage ovarian tumors. Cancer Res. 2001, 61: 5895-5904.
CAS
PubMed
Google Scholar
Troup S, Njue C, Kliewer EV, Parisien M, Roskelley C, Chakravarti S, Roughley PJ, Murphy LC, Watson PH: Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res. 2003, 9: 207-214.
CAS
PubMed
Google Scholar
Banerjee AG, Bhattacharyya I, Lydiatt WM, Vishwanatha JK: Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma. Cancer Res. 2003, 63: 7769-7776.
CAS
PubMed
Google Scholar
Zafiropoulos A, Nikitovic D, Katonis P, Tsatsakis A, Karamanos NK, Tzanakakis GN: Decorin-induced growth inhibition is overcome through protracted expression and activation of epidermal growth factor receptors in osteosarcoma cells. Mol Cancer Res. 2008, 6: 785-794. 10.1158/1541-7786.MCR-07-0165.
Article
CAS
PubMed
Google Scholar
Zafiropoulos A, Tzanakakis GN: Decorin-mediated effects in cancer cell biology. Connect Tissue Res. 2008, 49: 244-248. 10.1080/03008200802147746.
Article
CAS
PubMed
Google Scholar
Watanabe H, Iwase M, Ohashi M, Nagumo M: Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. Oral Oncol. 2002, 38: 670-679. 10.1016/S1368-8375(02)00006-4.
Article
CAS
PubMed
Google Scholar
Waugh DJ, Wilson C: The interleukin-8 pathway in cancer. Clin Cancer Res. 2008, 14: 6735-6741. 10.1158/1078-0432.CCR-07-4843.
Article
CAS
PubMed
Google Scholar
Groeneveld TW, Oroszlan M, Owens RT, Faber-Krol MC, Bakker AC, Arlaud GJ, McQuillan DJ, Kishore U, Daha MR, Roos A: Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins. J Immunol. 2005, 175: 4715-4723.
Article
CAS
PubMed
Google Scholar
Hu L, Crowe DL, Rheinwald JG, Chambon P, Gudas LJ: Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 1991, 51: 3972-3981.
CAS
PubMed
Google Scholar
Hsu S, Borke JL, Lewis JB, Singh B, Aiken AC, Huynh CT, Schuster GS, Caughman GB, Dickinson DP, Smith AK, et al: Transforming growth factor beta 1 dysregulation in a human oral carcinoma tumour progression model. Cell Prolif. 2002, 35: 183-192. 10.1046/j.1365-2184.2002.00237.x.
Article
CAS
PubMed
Google Scholar
Kuwahara I, Lillehoj EP, Lu W, Singh IS, Isohama Y, Miyata T, Kim KC: Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-{kappa}B activation via EGFR transactivation in a lung epithelial cell line. Am J Physiol Lung Cell Mol Physiol. 2006, 291: L407-416. 10.1152/ajplung.00471.2005.
Article
CAS
PubMed
Google Scholar
Roupe KM, Nybo M, Sjobring U, Alberius P, Schmidtchen A, Sorensen OE: Injury is a major inducer of epidermal innate immune responses during wound healing. J Invest Dermatol. 2010, 130: 1167-1177. 10.1038/jid.2009.284.
Article
CAS
PubMed
Google Scholar
Reiland J, Furcht LT, McCarthy JB: CXC-chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate. 1999, 41: 78-88. 10.1002/(SICI)1097-0045(19991001)41:2<78::AID-PROS2>3.0.CO;2-P.
Article
CAS
PubMed
Google Scholar
Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP: Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res. 2000, 6: 2104-2119.
CAS
PubMed
Google Scholar
Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M: Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol. 1997, 151: 1105-1113.
PubMed Central
CAS
PubMed
Google Scholar
Youngs SJ, Ali SA, Taub DD, Rees RC: Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer. 1997, 71: 257-266. 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D.
Article
CAS
PubMed
Google Scholar
Kitadai Y, Haruma K, Mukaida N, Ohmoto Y, Matsutani N, Yasui W, Yamamoto S, Sumii K, Kajiyama G, Fidler IJ, Tahara E: Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res. 2000, 6: 2735-2740.
CAS
PubMed
Google Scholar
Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ: Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res. 1994, 54: 3242-3247.
CAS
PubMed
Google Scholar
Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE: Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine. 2000, 12: 78-85. 10.1006/cyto.1999.0518.
Article
CAS
PubMed
Google Scholar
Moore BB, Arenberg DA, Stoy K, Morgan T, Addison CL, Morris SB, Glass M, Wilke C, Xue YY, Sitterding S, et al: Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol. 1999, 154: 1503-1512. 10.1016/S0002-9440(10)65404-1.
Article
PubMed Central
CAS
PubMed
Google Scholar
Fujisawa N, Sakao Y, Hayashi S, Hadden WA, Harmon CL, Miller EJ: alpha-Chemokine growth factors for adenocarcinomas; a synthetic peptide inhibitor for alpha-chemokines inhibits the growth of adenocarcinoma cell lines. J Cancer Res Clin Oncol. 2000, 126: 19-26. 10.1007/PL00008460.
Article
CAS
PubMed
Google Scholar
Hsu SC, Hung MC: Characterization of a novel tripartite nuclear localization sequence in the EGFR family. J Biol Chem. 2007, 282: 10432-10440. 10.1074/jbc.M610014200.
Article
CAS
PubMed
Google Scholar
Lo HW, Hsu SC, Hung MC: EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat. 2006, 95: 211-218. 10.1007/s10549-005-9011-0.
Article
CAS
PubMed
Google Scholar
Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, et al: Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell. 2004, 6: 251-261. 10.1016/j.ccr.2004.07.012.
Article
CAS
PubMed
Google Scholar
Marti U, Ruchti C, Kampf J, Thomas GA, Williams ED, Peter HJ, Gerber H, Burgi U: Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues. Thyroid. 2001, 11: 137-145. 10.1089/105072501300042785.
Article
CAS
PubMed
Google Scholar
Psyrri A, Yu Z, Weinberger PM, Sasaki C, Haffty B, Camp R, Rimm D, Burtness BA: Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Clin Cancer Res. 2005, 11: 5856-5862. 10.1158/1078-0432.CCR-05-0420.
Article
CAS
PubMed
Google Scholar
Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC: Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol. 2001, 3: 802-808. 10.1038/ncb0901-802.
Article
CAS
PubMed
Google Scholar
Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, Freilino ML, Graner MW, Wikstrand CJ, Bigner DD, et al: Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting. Clin Cancer Res. 2006, 12: 5064-5073. 10.1158/1078-0432.CCR-06-0913.
Article
CAS
PubMed
Google Scholar
Lo HW, Hung MC: Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer. 2006, 94: 184-188. 10.1038/sj.bjc.6602941.
Article
PubMed Central
CAS
PubMed
Google Scholar
Buchau AS: EGFR (trans)activation mediates IL-8 and distinct human antimicrobial peptide and protein production following skin injury. J Invest Dermatol. 2010, 130: 929-932. 10.1038/jid.2009.371.
Article
PubMed
Google Scholar